Physician profile
Anna L Imhoff
NPI 1063443737
$376.65
in general payments reported to CMS, 2019-2025
15 companies · $32.93 in 2025
The $32.93 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.38 · 2020: $16.94 · 2021: $103 · 2022: $32.31 · 2023: $111 · 2024: $57.78 · 2025: $32.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $38.88 | 2023-2024 | |
| Novo Nordisk INC | $36.68 | 2020-2024 | Rybelsus, Ozempic |
| Boston Scientific Corporation | $34.21 | 2023 | |
| Abbvie INC. | $32.93 | 2025 | |
| Lilly USA, LLC | $31.73 | 2022-2024 | Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $28.15 | 2021-2023 | Vaxneuvance, Gardasil 9, M-M-R II |
| Vanda Pharmaceuticals INC. | $24.22 | 2021 | |
| Abbott Laboratories | $23.65 | 2023 | Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $23.38 | 2019 | |
| Eisai INC. | $20.93 | 2021 | |
| Therapeuticsmd, INC. | $18.64 | 2022 | |
| Sanofi Pasteur INC. | $18.24 | 2023 | |
| Seqirus USA INC | $18.10 | 2021 | |
| Amgen INC. | $14.78 | 2021 | |
| Dexcom, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Imhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.